Ofloxacin
- Product NDC
- 70512-793
- Requested package NDC
- 70512-793-05
- 11-digit product format
- 705120793
- Labeler code
- 70512
- Product ID
- 70512-793_4572865e-3ba3-c17b-e063-6294a90a97fd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ofloxacin Ophthalmic Solution USP, 0.3%
- Dosage form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Labeler
- SOLA Pharmaceuticals, LLC
- Application
- ANDA217904
- Marketing category
- ANDA
- Marketing start
- 2024-04-30
- Substance
- OFLOXACIN
- Active strength
- 3 mg/mL
- Pharmacologic classes
- Quinolone Antimicrobial [EPC], Quinolones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A217904-001 | OFLOXACIN | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A217904-001 | AT |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A217904-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A217904-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A217904-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A217904-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A217904-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217904-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A217904-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A217904-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A217904-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A217904-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A217904-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A217904-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A217904-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A217904-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A217904-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A217904-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A217904-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A217904-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 | 8072bd15b7f6… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217904-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OPHTHALMIC | AT | 2024-04-12 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A217904-001 | AT | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A217904-001 | AT | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A217904-001 | AT | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A217904-001 | AT | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A217904-001 | AT | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217904-001 | AT | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A217904-001 | AT | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A217904-001 | AT | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A217904-001 | AT | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A217904-001 | AT | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A217904-001 | AT | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A217904-001 | AT | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A217904-001 | AT | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A217904-001 | AT | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A217904-001 | AT | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A217904-001 | AT | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A217904-001 | AT | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A217904-001 | AT | 1 | 8072bd15b7f6… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217904-001 | AT | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ofloxacin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OFLOXACIN | 3 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| A4P49JAZ9H | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 312075 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4ca27244-ed70-4868-b2d8-8f97c3a52148 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f9d82093-3de1-4841-9a42-67222d61a0cf | Product name | 4 | 20250515 |
| bbed5f06-a6b7-a443-70ac-77518a9524b7 | Product name | 7 | 20250311 |
| 41679fed-052c-574b-6b40-cadcbc315b79 | Product name | 2 | 20150401 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70512-793-05 | Ofloxacin | 1 in 1 BOX | SOLUTION/ DROPS | 1 | 3 | |
| 70512-793-05 | Ofloxacin | 5 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 5 | 3 | |
| 70512-793-10 | Ofloxacin | 10 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 10 | 3 | |
| 70512-793-10 | Ofloxacin | 1 in 1 BOX | SOLUTION/ DROPS | 1 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70512-793-05 | ML - Milliliter | 70512-793 | 2817dc50-50f5-4655-a16c-2a28dab960e4 | 1 | 2024-08-12 |
| 70512-793-10 | ML - Milliliter | 70512-793 | fd126b5a-b2d4-40aa-9d8d-aa4ceb912036 | 1 | 2024-08-12 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OFLOXACIN | OFLOXACIN | NuCare Pharmaceuticals, Inc. | 5d70a645-f02c-3151-e063-6394a90a9811 | 2026-10-09 | Warnings, Adverse reactions | 217904 ANDA217904 |
| Ofloxacin | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | SOLA Pharmaceuticals, LLC | 4ca27244-ed70-4868-b2d8-8f97c3a52148 | 2025-12-08 | Warnings, Adverse reactions | 217904 ANDA217904 70512-793-05 70512-793 70512079305 |
| Ofloxacin | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | Caplin Steriles Limited | 53f7ec2e-5b4c-4f8c-b8ba-7f8844e0c01b | 2025-02-05 | Warnings, Adverse reactions | 217904 ANDA217904 |
| OFLOXACIN | OFLOXACIN | Leading Pharma, LLC | 7552729e-a41e-4eb1-8b37-b48a86112790 | 2024-07-01 | Warnings, Adverse reactions | 217904 ANDA217904 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 312075 | ofloxacin 0.3 % Ophthalmic Solution | PSN | 4ca27244-ed70-4868-b2d8-8f97c3a52148 | 3 |
| 312075 | ofloxacin 3 MG/ML Ophthalmic Solution | SCD | 4ca27244-ed70-4868-b2d8-8f97c3a52148 | 3 |
| 312075 | ofloxacin 0.3 % Ophthalmic Solution | SY | 4ca27244-ed70-4868-b2d8-8f97c3a52148 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 70512-793-05 | 70512079305 | 1 BOTTLE, DROPPER in 1 BOX (70512-793-05) / 5 mL in 1 BOTTLE, DROPPER | 2024-04-30 | No | No | Current |